Efficacy of Sorafenib Combined With Immunotherapy Following Transarterial Chemoembolization for Advanced Hepatocellular Carcinoma: A Propensity Score Analysis

AIM: The aim of the study is to compare the efficacy and safety of monotherapy with a sequential immune checkpoint inhibitor (ICI) programmed cell death protein-1 (PD-1) and its combination with multi-target drug sorafenib after transcatheter arterial chemoembolization (TACE) for advanced hepatocell...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Jian, Huang, Yusheng, Zhou, Hanjing, Yi, Shouhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024171/
https://www.ncbi.nlm.nih.gov/pubmed/35463356
http://dx.doi.org/10.3389/fonc.2022.807102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024171/
https://www.ncbi.nlm.nih.gov/pubmed/35463356
http://dx.doi.org/10.3389/fonc.2022.807102

Ejemplares similares